Abstract |
The acute hepatic porphyrias are inherited disorders of heme biosynthesis characterized by life-threatening acute neurovisceral attacks. Factors that induce the expression of hepatic 5-aminolevulinic acid synthase 1 (ALAS1) result in the accumulation of the neurotoxic porphyrin precursors 5-aminolevulinic acid (ALA) and porphobilinogen (PBG), which recent studies indicate are primarily responsible for the acute attacks. Current treatment of these attacks involves i.v. administration of hemin, but a faster-acting, more effective, and safer therapy is needed. Here, we describe preclinical studies of liver-directed small interfering RNAs (siRNAs) targeting Alas1 (Alas1-siRNAs) in a mouse model of acute intermittent porphyria, the most common acute hepatic porphyria. A single i.v. dose of Alas1-siRNA prevented the phenobarbital-induced biochemical acute attacks for approximately 2 wk. Injection of Alas1-siRNA during an induced acute attack significantly decreased plasma ALA and PBG levels within 8 h, more rapidly and effectively than a single hemin infusion. Alas1-siRNA was well tolerated and a therapeutic dose did not cause hepatic heme deficiency. These studies provide proof-of-concept for the clinical development of RNA interference therapy for the prevention and treatment of the acute attacks of the acute hepatic porphyrias.
|
Authors | Makiko Yasuda, Lin Gan, Brenden Chen, Senkottuvelan Kadirvel, Chunli Yu, John D Phillips, Maria I New, Abigail Liebow, Kevin Fitzgerald, William Querbes, Robert J Desnick |
Journal | Proceedings of the National Academy of Sciences of the United States of America
(Proc Natl Acad Sci U S A)
Vol. 111
Issue 21
Pg. 7777-82
(May 27 2014)
ISSN: 1091-6490 [Electronic] United States |
PMID | 24821812
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Validation Study)
|
Chemical References |
- RNA, Small Interfering
- 5-Aminolevulinate Synthetase
|
Topics |
- 5-Aminolevulinate Synthetase
(genetics, metabolism)
- Analysis of Variance
- Animals
- Blotting, Western
- Drug Evaluation, Preclinical
- Electrophoresis, Polyacrylamide Gel
- Female
- Liver
(metabolism)
- Mice
- Mice, Inbred C57BL
- Particle Size
- Porphyria, Acute Intermittent
(prevention & control)
- RNA Interference
(drug effects, immunology)
- RNA, Small Interfering
(pharmacology)
- Real-Time Polymerase Chain Reaction
|